Search details
1.
HER2-low heterogeneity between primary and paired recurrent/metastatic breast cancer: Implications in treatment and prognosis.
Cancer
; 130(6): 851-862, 2024 03 15.
Article
in English
| MEDLINE | ID: mdl-37933913
2.
Incidence and prognostic significance of receptor discordance between primary breast cancer and paired bone metastases.
Int J Cancer
; 152(7): 1476-1489, 2023 04 01.
Article
in English
| MEDLINE | ID: mdl-36408915
3.
Identification of Key Genes Associated with Brain Metastasis from Breast Cancer: A Bioinformatics Analysis.
Med Sci Monit
; 28: e935071, 2022 Mar 17.
Article
in English
| MEDLINE | ID: mdl-35296631
4.
SARS-CoV-2-specific antibody response characteristics in COVID-19 patients of different ages.
Acta Biochim Biophys Sin (Shanghai)
; 54(4): 556-564, 2022 Apr 25.
Article
in English
| MEDLINE | ID: mdl-35607955
5.
Cisplatin given at three divided doses for three consecutive days in metastatic breast cancer: an alternative schedule for one full dose with comparable efficacy but less CINV and hypomagnesaemia.
Breast Cancer Res Treat
; 182(3): 719-726, 2020 Aug.
Article
in English
| MEDLINE | ID: mdl-32524355
6.
Mutation analysis of 19 autosomal short tandem repeats in Chinese Han population from Shanghai.
Int J Legal Med
; 130(6): 1439-1444, 2016 Nov.
Article
in English
| MEDLINE | ID: mdl-27470316
7.
NF-κB signaling in therapy resistance of breast cancer: Mechanisms, approaches, and challenges.
Life Sci
; 348: 122684, 2024 Jul 01.
Article
in English
| MEDLINE | ID: mdl-38710275
8.
Treatment patterns and clinical outcomes of chidamide combined with endocrine therapy in hormone receptor-positive, HER2-negative metastatic breast cancer: A real-world multicenter study.
Cancer Med
; 13(4): e6762, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38457252
9.
NF-κB in biology and targeted therapy: new insights and translational implications.
Signal Transduct Target Ther
; 9(1): 53, 2024 Mar 04.
Article
in English
| MEDLINE | ID: mdl-38433280
10.
Age- and Severity-Associated Humoral Immunity Response in COVID-19 Patients: A Cohort Study from Wuhan, China.
J Clin Med
; 11(19)2022 Oct 10.
Article
in English
| MEDLINE | ID: mdl-36233840
11.
Determination and clinical significance of bone pseudoprogression in hormone receptor-positive metastatic breast cancer.
Ther Adv Med Oncol
; 13: 17588359211022881, 2021.
Article
in English
| MEDLINE | ID: mdl-34188696
12.
Development and validation of a nomogram for predicting overall survival of patients with cancer of unknown primary: a real-world data analysis.
Ann Transl Med
; 9(3): 198, 2021 Feb.
Article
in English
| MEDLINE | ID: mdl-33708825
13.
COVID-ONE-hi: The One-stop Database for COVID-19-specific Humoral Immunity and Clinical Parameters.
Genomics Proteomics Bioinformatics
; 19(5): 669-678, 2021 10.
Article
in English
| MEDLINE | ID: mdl-34748989
14.
Comparative Overall Survival of CDK4/6 Inhibitors Plus Endocrine Therapy vs. Endocrine Therapy Alone for Hormone receptor-positive, HER2-negative metastatic breast cancer.
J Cancer
; 11(24): 7127-7136, 2020.
Article
in English
| MEDLINE | ID: mdl-33193875
15.
A risk stratification model for predicting brain metastasis and brain screening benefit in patients with metastatic triple-negative breast cancer.
Cancer Med
; 9(22): 8540-8551, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32945619
16.
Real-World Data of Pyrotinib-Based Therapy in Metastatic HER2-Positive Breast Cancer: Promising Efficacy in Lapatinib-Treated Patients and in Brain Metastasis.
Cancer Res Treat
; 52(4): 1059-1066, 2020 Oct.
Article
in English
| MEDLINE | ID: mdl-32340083
Results
1 -
16
de 16
1
Next >
>>